pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
evolocumab
Repatha (evolocumab)
Atherosclerosis
$AMGN
AMGEN INC
Phase 3
evorpacept
evorpacept
Adenocarcinoma Of The Gastroesophageal Junction
$ALXO
ALX ONCOLOGY HOLDINGS INC
Preclinical
exRP-250
Psoriasis
exRNA Therapeutics Ltd
Phase 3
← prev
page 178 of 231
next →
Pain
89
Neurology
1
exagamglogene autotemcel
Casgevy (exagamglogene autotemcel)
Beta Thalassaemia
$VERX
Vertex, Inc.
Phase 2
exaluren
exaluren [INN]
Alport Syndrome
$ELOX
Eloxx Pharmaceuticals, Inc.
Phase 1
exarafenib
exarafenib [INN]
Melanoma
Laboratoires Pierre Fabre SA
Phase 1
exenatide
Byetta (exenatide)
Type 2 Diabetes
$ORMP
ORAMED PHARMACEUTICALS INC.
Phase 2
exendin-(9-39)
Hyperinsulinemia
Children's Hospital of Philadelphia
Phase 2
exeporfinium chloride
exeporfinium chloride [INN]
Hospital Acquired Methicillin-Resistant Staphylococcus au…
AMR Bio Ltd
Phase 2
ezeprogind
ezeprogind [INN]
Progressive Supranuclear Palsy
AlzProtect SAS
Marketed
ezetimibe
Ezetimibe
Heterozygous Familial Hypercholesterolemia (heFH)
OEP Pharma
Phase 2
ezurpimtrostat
ezurpimtrostat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Genfit SA
Marketed
factor IX complex
Profilnine SD (factor IX complex)
Hemophilia B (Factor IX Deficiency)
Grifols Biologicals Inc (Inactive)
Marketed
factor XIII (human)
Corifact (factor XIII (human))
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficie…
CSL Behring LLC
Phase 1
faldoritinib
faldoritinib
Refractory Acute Myeloid Leukemia
$BMEA
Biomea Fusion, Inc.
Marketed
famciclovir
Famciclovir
Genital Herpes
Camber Pharmaceuticals Inc
Marketed
famotidine
Pepcid (famotidine)
Acid Indigestion (Heartburn/Pyrosis)
$KVUE
Kenvue Inc.
Phase 2
famzeretcel
famzeretcel [INN]
Retinitis Pigmentosa (Retinitis)
jCyte Inc
Phase 1
farabursen sodium
farabursen sodium
Polycystic Kidney Disease
$NVS
NOVARTIS AG
Phase 1
faridoxorubicin
faridoxorubicin [INN]
Dedifferentiated Liposarcoma
Avacta Life Sciences Ltd
Phase 2
farletuzumab ecteribulin
farletuzumab ecteribulin
Triple-Negative Breast Cancer (TNBC)
Eisai Co Ltd
Phase 3
fasedienol
Aloradine (fasedienol)
Social Anxiety Disorder (SAD/Social Phobia)
$VTGN
Vistagen Therapeutics, Inc.
Phase 2
fasudil
BRAVYL (fasudil [INN])
Amyotrophic Lateral Sclerosis
Woolsey Pharmaceuticals Inc
Phase 3
fazirsiran sodium
fazirsiran sodium
Alpha-1 Antitrypsin Deficiency (A1AD)
$ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Phase 1
fb-PMT
Recurrent Glioblastoma Multiforme (GBM)
NanoPharmaceuticals LLC
Marketed
fecal microbiota, live-brpk
Vowst
Clostridioides difficile Infections (Clostridium difficil…
Nestle HealthCare Nutrition Inc
Marketed
fecal microbiota, live-jslm
Rebyota
Clostridioides difficile Infections (Clostridium difficil…
Ferring Pharmaceuticals Inc
Marketed
felbamate
Felbamate Wallace (felbamate)
Generalized Seizures
Wallace Pharmaceuticals Inc
Marketed
felodipine ER
Felodipine
Hypertension
Method Pharmaceuticals LLC
Phase 3
felzartamab
felzartamab [INN]
Membranous Glomerulonephritis
$BIIB
BIOGEN INC.